JAMA Oncology : Erlotinib and the Risk of Oral Cancer

Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
Source: JAMA Specialty Journals Author Interviews - Category: Journals (General) Authors: Source Type: podcasts